FDA allows ReNetX's IND for first-in-human study of AXER-204 to treat spinal cord injury June 21, 2019
Updated positive results for phase Ib study of resiniferatoxin in knee osteoarthritis pain June 20, 2019
Regeneron Pharmaceuticals initiates phase II study of REGN-5069 in osteoarthritis of the knee June 18, 2019
RSS